authors
- Hillis, Christopher
- Jackson Chornenki, Nicholas L
- Bence-Bruckler, Isabelle
- Busque, Lambert
- Cote, Yvan
- Hamm, Caroline
- Hasegawa, Wanda
- Kamel-Reid, Suzanne
- Savoie, Lynn
- Turner, A Robert
- Xenocostas, Anargyros
- Lipton, Jeffrey H
- Leber, Brian
The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 2020
has subject area
- 1103 Clinical Sciences (FoR)
- Biological Availability (MeSH)
- Dose-Response Relationship, Drug (MeSH)
- Female (MeSH)
- Gene Expression Regulation, Leukemic (MeSH)
- Genes, abl (MeSH)
- Humans (MeSH)
- Imatinib Mesylate (MeSH)
- Immunology (Science Metrix)
- Intracellular Space (MeSH)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive (MeSH)
- Male (MeSH)
- Octamer Transcription Factor-1 (MeSH)
- Predictive Value of Tests (MeSH)
- Prognosis (MeSH)
- Sensitivity and Specificity (MeSH)
- Treatment Outcome (MeSH)
published in
- Leukemia Research Journal